Andrew Stewart Plump
Director, President, R&D · 5 filings · Latest: Sep 2, 2026
TAKEDA PHARMACEUTICAL CO LTD
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TAK | Andrew Stewart Plump | Director, President, R&D | Sep 2, 2026 | Sale | $18.49 | 116,191 | $2.1M | 145,465 | |
TAK | Plump Andrew Stewart | — | Sep 2, 2026 | Proposed Sale | $18.49 | 116,191 | $2.1M | — | |
TAK | Andrew Stewart Plump | Director, President, R&D | Aug 19, 2026 | Sale | $18.49 | 19,651 | $363.3K | 261,656 | |
TAK | Plump Andrew Stewart | — | Aug 19, 2026 | Proposed Sale | $18.49 | 19,651 | $363.3K | — | |
TAK | Andrew Stewart Plump | Director, President, R&D | Aug 10, 2026 | Sale | $17.10 | 165,393 | $2.8M | 766,569 | |
TAK | Andrew Plump | — | Jul 13, 2026 | Proposed Sale | $16.75 | 179,239 | $3.0M | — | |
TAK | Andrew Plump | — | Jul 9, 2025 | Proposed Sale | $15.42 | 169,313 | $2.6M | — |